The enhanced expression of surface nucleolin is observed in vitro and in vivo in lymphoid organs containing activated lymphocytes, on the surface of tumor and endothelial cells, or in angiogenic endothelial cells within the tumor vasculature [6], [13], [31], [52]. This evidence concerns the gene NUCLEOLIN and neoplasm.